| The precuneus: a review of its functional anatomy and behavioural correlates AE Cavanna, MR Trimble Brain 129 (3), 564-583, 2006 | 5389 | 2006 |
| European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment V Roessner, KJ Plessen, A Rothenberger, AG Ludolph, R Rizzo, L Skov, ... European child & adolescent psychiatry 20, 173-196, 2011 | 533 | 2011 |
| The precuneus and consciousness AE Cavanna CNS spectrums 12 (7), 545-552, 2007 | 410 | 2007 |
| The cognitive impact of antiepileptic drugs CM Eddy, HE Rickards, AE Cavanna Therapeutic advances in neurological disorders 4 (6), 385-407, 2011 | 397 | 2011 |
| The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective MM Robertson, V Eapen, AE Cavanna Journal of psychosomatic research 67 (6), 475-483, 2009 | 349 | 2009 |
| The behavioral spectrum of Gilles de la Tourette syndrome AE Cavanna, S Servo, F Monaco, MM Robertson The Journal of neuropsychiatry and clinical neurosciences 21 (1), 13-23, 2009 | 343 | 2009 |
| Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders T Pringsheim, MS Okun, K Müller-Vahl, D Martino, J Jankovic, ... Neurology 92 (19), 896-906, 2019 | 300 | 2019 |
| Functional connectivity and coactivation of the nucleus accumbens: a combined functional connectivity and structure-based meta-analysis F Cauda, AE Cavanna, F D'agata, K Sacco, S Duca, GC Geminiani Journal of cognitive neuroscience 23 (10), 2864-2877, 2011 | 214 | 2011 |
| Quality of life in young people with Tourette syndrome: a controlled study CM Eddy, R Rizzo, M Gulisano, A Agodi, M Barchitta, P Calì, ... Journal of neurology 258, 291-301, 2011 | 213 | 2011 |
| The Gilles de la Tourette syndrome–quality of life scale (GTS-QOL): development and validation AE Cavanna, A Schrag, D Morley, M Orth, MM Robertson, E Joyce, ... Neurology 71 (18), 1410-1416, 2008 | 206 | 2008 |
| Thalamic deep brain stimulation for treatment-refractory Tourette syndrome: two-year outcome M Porta, A Brambilla, AE Cavanna, D Servello, M Sassi, H Rickards, ... Neurology 73 (17), 1375-1380, 2009 | 204 | 2009 |
| Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients A Pollo, E Torre, L Lopiano, M Rizzone, M Lanotte, A Cavanna, ... Neuroreport 13 (11), 1383-1386, 2002 | 200 | 2002 |
| European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation KR Müller-Vahl, DC Cath, AE Cavanna, S Dehning, M Porta, ... European child & adolescent psychiatry 20, 209-217, 2011 | 198 | 2011 |
| Multispectral brain morphometry in Tourette syndrome persisting into adulthood B Draganski, D Martino, AE Cavanna, C Hutton, M Orth, MM Robertson, ... Brain 133 (12), 3661-3675, 2010 | 164 | 2010 |
| Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders T Pringsheim, Y Holler-Managan, MS Okun, J Jankovic, J Piacentini, ... Neurology 92 (19), 907-915, 2019 | 162 | 2019 |
| Comorbidities, social impact, and quality of life in Tourette syndrome V Eapen, AE Cavanna, MM Robertson Frontiers in psychiatry 7, 97, 2016 | 161 | 2016 |
| Functional neuroanatomy and neurophysiology of functional neurological disorders (conversion disorder) V Voon, AE Cavanna, K Coburn, S Sampson, A Reeve, WC LaFrance Jr, ... The Journal of Neuropsychiatry and Clinical Neurosciences 28 (3), 168-190, 2016 | 152 | 2016 |
| Treatment strategies for tics in Tourette syndrome CM Eddy, HE Rickards, AE Cavanna Therapeutic Advances in Neurological Disorders 4 (1), 25-45, 2011 | 148 | 2011 |
| Insights from the third international conference on hyperacusis: causes, evaluation, diagnosis, and treatment H Aazh, M Knipper, AA Danesh, AE Cavanna, L Andersson, J Paulin, ... Noise & health 20 (95), 162, 2018 | 143 | 2018 |
| Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations J Piedad, H Rickards, FMC Besag, AE Cavanna CNS drugs 26, 319-335, 2012 | 141 | 2012 |
